In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Pharmacy benefit management giant Express Scripts unveiled several steps it's taking to boost transparency and mitigate high ...
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
Cedar Rapids KCRG-TV on MSN2h
State lawmakers to consider Pharmacy Benefit Manager reform after 29 Iowa pharmacies closed in 2024Bills in the Iowa House and Senate would change how pharmacy benefit managers, or PBMs, mediate pharmacies and insurance ...
Trump's pick for HHS Secretary faces questions from the left and right over his health stances. But will that stop his ...
"You got to figure out how to work with him, right?" PBM reform is top of mind for drugmakers. They argue that the middlemen overcharge insurance plans for which they negotiate medication rebates ...
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback